Estimated Burden of Stroke in China in 2020

Wen‐Jun Tu(Capital Medical University), Zhenping Zhao(National Center for Chronic and Noncommunicable Disease Control and Prevention), Peng Yin(National Center for Chronic and Noncommunicable Disease Control and Prevention), Lei Cao(National Health and Family Planning Commission), Jingsheng Zeng(Sun Yat-sen University), Dawei Chen(General Hospital of Shenyang Military Region), Dongsheng Fan(Peking University), Qi Fang(Soochow University), Pei Gao(Peking University), Yuxiang Gu(Fudan University), Guo-Jun Tan(Hebei Medical University), Jianfeng Han(First Affiliated Hospital of Xi'an Jiaotong University), Li He(Sichuan University), Bo Hu(Union Hospital), Hua Yang(Capital Medical University), Dezhi Kang(Fujian Medical University), Hongyan Li(People's Hospital of Xinjiang Uygur Autonomous Region), Jianmin Liu(Second Military Medical University), Yuanli Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Min Lou(Second Affiliated Hospital of Zhejiang University), Benyan Luo(First Affiliated Hospital Zhejiang University), Suyue Pan(Nanfang Hospital), Bin Peng(Chinese Academy of Medical Sciences & Peking Union Medical College), Lijie Ren(Shenzhen Second People's Hospital), Lihua Wang(Harbin Medical University), Jian Wu(Beijing Tsinghua Chang Gung Hospital), Yuming Xu(Nanjing Drum Tower Hospital), Yun Xu(Nanjing Drum Tower Hospital), Yi Yang(First Bethune Hospital of Jilin University), Meng Zhang(Army Medical University), Shu Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Liangfu Zhu(Henan Provincial People's Hospital), Yi‐Cheng Zhu(Chinese Academy of Medical Sciences & Peking Union Medical College), Zixiao Li(Capital Medical University), Lan Chu(Guiyang Medical University), Xiuli An(Harbin Medical University), Lingxiao Wang(Harbin Medical University), Meng Yin(National Health and Family Planning Commission), Mei Li(Hebei Provincial Center for Disease Control and Prevention), Li Yin(Hunan Provincial Center for Disease Control and Prevention), Wei Qi Yan(Nanchang Center for Disease Control and Prevention), Chuan Li(Guangdong Provincial Center for Disease Control and Prevention), Junli Tang(Shandong Center for Disease Control and Prevention), Maigeng Zhou(National Center for Chronic and Noncommunicable Disease Control and Prevention), Longde Wang(Harbin Medical University)
JAMA Network Open
March 2, 2023
Cited by 554Open Access
Full Text

Abstract

Importance: Stroke is the leading cause of death in China. However, recent data about the up-to-date stroke burden in China are limited. Objective: To investigate the urban-rural disparity of stroke burden in the Chinese adult population, including prevalence, incidence, and mortality rate, and disparities between urban and rural populations. Design, Setting, and Participants: This cross-sectional study was based on a nationally representative survey that included 676 394 participants aged 40 years and older. It was conducted from July 2020 to December 2020 in 31 provinces in mainland China. Main Outcomes and Measures: Primary outcome was self-reported stroke verified by trained neurologists during a face-to-face interviews using a standardized protocol. Stroke incidence were assessed by defining first-ever strokes that occurred during 1 year preceding the survey. Strokes causing death that occurred during the 1 year preceding the survey were considered as death cases. Results: The study included 676 394 Chinese adults (395 122 [58.4%] females; mean [SD] age, 59.7 [11.0] years). In 2020, the weighted prevalence, incidence, and mortality rates of stroke in China were 2.6% (95% CI, 2.6%-2.6%), 505.2 (95% CI, 488.5-522.0) per 100 000 person-years, and 343.4 (95% CI, 329.6-357.2) per 100 000 person-years, respectively. It was estimated that among the Chinese population aged 40 years and older in 2020, there were 3.4 (95% CI, 3.3-3.6) million incident cases of stroke, 17.8 (95% CI, 17.5-18.0) million prevalent cases of stroke, and 2.3 (95% CI, 2.2-2.4) million deaths from stroke. Ischemic stroke constituted 15.5 (95% CI, 15.2-15.6) million (86.8%) of all incident strokes in 2020, while intracerebral hemorrhage constituted 2.1 (95% CI, 2.1-2.1) million (11.9%) and subarachnoid hemorrhage constituted 0.2 (95% CI, 0.2-0.2) million (1.3%). The prevalence of stroke was higher in urban than in rural areas (2.7% [95% CI, 2.6%-2.7%] vs 2.5% [95% CI, 2.5%-2.6%]; P = .02), but the incidence rate (485.5 [95% CI, 462.8-508.3] vs 520.8 [95% CI, 496.3-545.2] per 100 000 person-years; P < .001) and mortality rate (309.9 [95% CI, 291.7-328.1] vs 369.7 [95% CI, 349.1-390.3] per 100 000 person-years; P < .001) were lower in urban areas than in rural areas. In 2020, the leading risk factor for stroke was hypertension (OR, 3.20 [95% CI, 3.09-3.32]). Conclusions and Relevance: In a large, nationally representative sample of adults aged 40 years or older, the estimated prevalence, incidence, and mortality rate of stroke in China in 2020 were 2.6%, 505.2 per 100 000 person-years, and 343.4 per 100 000 person-years, respectively, indicating the need for an improved stroke prevention strategy in the general Chinese population.


Related Papers

No related papers found

Powered by citation graph analysis